Research Paper Volume 15, Issue 4 pp 1074—1106

An immune-related prognostic signature associated with immune landscape and therapeutic responses in gastric cancer


Figure 8. The analysis of TIDE score and expression of immune checkpoints in high- and low-risk groups. (AC) The expression of PD1, PD-L1, and CTLA4 in different risk groups. (DF) The co-expression patterns between immune checkpoints and risk scores. (GI) The scores of immune dysfunction, immune exclusion, and TIDE in different risk groups.